4//SEC Filing
York Michael 4
Accession 0001169245-21-000044
CIK 0001169245other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 6:10 PM ET
Size
4.9 KB
Accession
0001169245-21-000044
Insider Transaction Report
Form 4
York Michael
VP, Corporate Development
Transactions
- Award
Common Stock
2021-05-20$2.80/sh+2,897$8,112→ 7,059 total
Footnotes (1)
- [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001755422
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 6:10 PM ET
- Size
- 4.9 KB